Conferences and symposiums Highlight the World Tuberculosis day.
The title of the talk is: Defining T cell targets in tuberculosis: Immunological discovery, characterization and clinical translation: From systematic epitope mapping to the clinical evaluation of the novel TB vaccine candidate H107e/CAF10b
Speaker
Dr. Cecilia Lindestam Arlehamn
Cecilia recently joined Statens serum institute after several very successful years at La Jolla Institute for Immunology. Her research has focused on conventional and unconventional T cell responses to infection, especially TB, and in neurodegenerative disease.
For those who cannot attend in person, please use the zoom link: https://ki-se.zoom.us/j/62456197022
Selected recent publications by Cecilia
Minimal immune cell subset differences in a cohort of close contacts of tuberculosis index cases.
Panda S, Cheng C, Hillery N, Catanzaro DG, Ciobanu N, Crudu V, Rodwell T, Catanzaro A, Burel JG, Peters B, Lindestam Arlehamn CS
Tuberculosis (Edinb) 2025 Dec;155():102707
Effector Functions of Conventional and Unconventional Mycobacterium tuberculosis (Mtb)-Specific T Cells.
Panda S, Kearns K, Lindestam Arlehamn CS
Cold Spring Harb Perspect Med 2026 Feb;16(2):
PINK1 is a target of T cell responses in Parkinson's disease.
Williams GP, Freuchet A, Michaelis T, Frazier A, Tran NK, Rodrigues Lima-Junior J, Phillips EJ, Mallal SA, Litvan I, Goldman JG, Alcalay RN, Sidney J, Sulzer D, Sette A, Lindestam Arlehamn CS
J Clin Invest 2024 Dec;135(4):
Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection.
Panda S, Morgan J, Cheng C, Saito M, Gilman RH, Ciobanu N, Crudu V, Catanzaro DG, Catanzaro A, Rodwell T, Perera JSB, Chathuranga T, Gunasena B, DeSilva AD, Peters B, Sette A, Lindestam Arlehamn CS
Nat Commun 2024 Jan;15(1):765
Antigen-specificity measurements are the key to understanding T cell responses.
Tippalagama R, Chihab LY, Kearns K, Lewis S, Panda S, Willemsen L, Burel JG, Lindestam Arlehamn CS
Front Immunol 2023 ;14():1127470